Published on Medical Design Technology (http://www.mdtmag.com)

Home > Seaside Therapeutics research sees possible autism treatment

Seaside Therapeutics research sees possible autism treatment

Mass High Tech: The Journal of New England Technology

Seaside Therapeutics Inc. in Cambridge Wednesday published its latest research results for its disease-modifying drug candidate STX209 that shows promise as a treatment for fragile X syndrome and autism, the most prevalent form of intellectual disability.

Source URL (retrieved on 06/18/2013 - 1:46am): http://www.mdtmag.com/news/2012/09/seaside-therapeutics-research-sees-possible-autism-treatment